Validation of Serum Neurofilament Light Chain as a Biomarker of Parkinson’s Disease Progression

Serum NFL discriminates Parkinson disease from atypical parkinsonisms

(2019) Tainá M. Marques et al.   NEUROLOGY

Association Between Longitudinal Plasma Neurofilament Light and Neurodegeneration in Patients With Alzheimer Disease

(2019) Niklas Mattsson et al.   JAMA Neurology

Diagnostic Value of Cerebrospinal Fluid Neurofilament Light Protein in Neurology

(2019) Claire Bridel et al.   JAMA Neurology

Blood NfL

(2019) Chin-Hsien Lin et al.   NEUROLOGY

Neurofilaments in pre-symptomatic ALS and the impact of genotype

(2019) Michael Benatar et al.   Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration

Baseline predictors for progression 4 years after Parkinson's disease diagnosis in the De Novo Parkinson Cohort (DeNoPa)

(2018) Brit Mollenhauer et al.   MOVEMENT DISORDERS

Blood-based NfL

(2017) Oskar Hansson et al.   NEUROLOGY

Multiple modality biomarker prediction of cognitive impairment in prospectively followed de novo Parkinson disease

(2017) Chelsea Caspell-Garcia et al.   PLoS One

Monitoring of 30 marker candidates in early Parkinson disease as progression markers

(2016) Brit Mollenhauer et al.   NEUROLOGY

Longitudinal changes in cognition in early Parkinson's disease patients with REM sleep behavior disorder

(2016) L.M. Chahine et al.   PARKINSONISM & RELATED DISORDERS

Multicenter immunoassay validation of cerebrospinal fluid neurofilament light: a biomarker for neurodegeneration

(2016) Anne-Marie Miller et al.   Bioanalysis

Association of Cerebrospinal Fluid Neurofilament Light Concentration With Alzheimer Disease Progression

(2016) Henrik Zetterberg et al.   JAMA Neurology

Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis

(2015) M Alba Mañé Martínez et al.   Multiple Sclerosis Journal

Cerebrospinal Fluid Patterns and the Risk of Future Dementia in Early, Incident Parkinson Disease

(2015) David C. Bäckström et al.   JAMA Neurology

Glial and neuronal markers in cerebrospinal fluid predict progression in multiple sclerosis

(2015) M Alba Mañé Martínez et al.   Multiple Sclerosis Journal

Low clinical diagnostic accuracy of early vs advanced Parkinson disease: Clinicopathologic study

(2014) C. H. Adler et al.   NEUROLOGY

Blood Biomarkers for Brain Injury in Concussed Professional Ice Hockey Players

(2014) Pashtun Shahim et al.   JAMA Neurology

Nonmotor and diagnostic findings in subjects with de novo Parkinson disease of the DeNoPa cohort

(2013) B. Mollenhauer et al.   NEUROLOGY

Increased Neurofilament Light Chain Blood Levels in Neurodegenerative Neurological Diseases

(2013) Johanna Gaiottino et al.   PLoS One

Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease

(2012) Randall J. Bateman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Quantification of α-synuclein in cerebrospinal fluid as a biomarker candidate: review of the literature and considerations for future studies

(2010) Brit Mollenhauer et al.   Biomarkers in Medicine

Systematic review of levodopa dose equivalency reporting in Parkinson's disease

(2010) Claire L. Tomlinson et al.   MOVEMENT DISORDERS

The progression of pathology in longitudinally followed patients with Parkinson’s disease

(2008) Glenda Halliday et al.   ACTA NEUROPATHOLOGICA

Movement Disorder Society-sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS-UPDRS): Scale presentation and clinimetric testing results

(2008) Christopher G. Goetz et al.   MOVEMENT DISORDERS